1. Home
  2. GNLX vs SA Comparison

GNLX vs SA Comparison

Compare GNLX & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • SA
  • Stock Information
  • Founded
  • GNLX 2001
  • SA 1979
  • Country
  • GNLX United States
  • SA Canada
  • Employees
  • GNLX N/A
  • SA N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • SA Precious Metals
  • Sector
  • GNLX Health Care
  • SA Basic Materials
  • Exchange
  • GNLX Nasdaq
  • SA Nasdaq
  • Market Cap
  • GNLX 107.1M
  • SA N/A
  • IPO Year
  • GNLX 2023
  • SA N/A
  • Fundamental
  • Price
  • GNLX $3.07
  • SA $17.08
  • Analyst Decision
  • GNLX Strong Buy
  • SA
  • Analyst Count
  • GNLX 4
  • SA 0
  • Target Price
  • GNLX $18.75
  • SA N/A
  • AVG Volume (30 Days)
  • GNLX 172.0K
  • SA 511.7K
  • Earning Date
  • GNLX 11-12-2024
  • SA 11-15-2024
  • Dividend Yield
  • GNLX N/A
  • SA N/A
  • EPS Growth
  • GNLX N/A
  • SA N/A
  • EPS
  • GNLX N/A
  • SA 0.08
  • Revenue
  • GNLX $8,000.00
  • SA N/A
  • Revenue This Year
  • GNLX N/A
  • SA N/A
  • Revenue Next Year
  • GNLX N/A
  • SA N/A
  • P/E Ratio
  • GNLX N/A
  • SA $213.55
  • Revenue Growth
  • GNLX N/A
  • SA N/A
  • 52 Week Low
  • GNLX $1.60
  • SA $9.31
  • 52 Week High
  • GNLX $17.48
  • SA $20.55
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 59.37
  • SA 42.91
  • Support Level
  • GNLX $2.98
  • SA $18.41
  • Resistance Level
  • GNLX $3.50
  • SA $19.09
  • Average True Range (ATR)
  • GNLX 0.31
  • SA 0.70
  • MACD
  • GNLX 0.04
  • SA -0.21
  • Stochastic Oscillator
  • GNLX 55.50
  • SA 2.77

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: